PepGen Inc (PEPG)
14.56
+0.32
(+2.25%)
USD |
NASDAQ |
May 24, 16:00
14.60
+0.04
(+0.27%)
After-Hours: 20:00
PepGen Cash from Financing (Quarterly): 86.97M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 86.97M |
| December 31, 2023 | 0.026M |
| September 30, 2023 | -0.534M |
| June 30, 2023 | 0.189M |
| March 31, 2023 | 0.13M |
| December 31, 2022 | 0.217M |
| September 30, 2022 | -1.42M |
| Date | Value |
|---|---|
| June 30, 2022 | 113.41M |
| March 31, 2022 | -0.018M |
| December 31, 2021 | -1.027M |
| September 30, 2021 | 132.87M |
| June 30, 2021 | 15.81M |
| March 31, 2021 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.42M
Minimum
Sep 2022
132.87M
Maximum
Sep 2021
26.66M
Average
0.13M
Median
Mar 2023
Cash from Financing (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 141.05M |
| Vertex Pharmaceuticals Inc | -357.50M |
| Sarepta Therapeutics Inc | 22.14M |
| PTC Therapeutics Inc | 0.54M |
| Regenxbio Inc | 120.72M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -22.53M |
| Cash from Investing (Quarterly) | -11.29M |
| Free Cash Flow | -77.58M |
| Free Cash Flow Per Share (Quarterly) | -0.7881 |
| Free Cash Flow Yield | -21.30% |